Business Description
Core Laboratories Inc
NAICS : 213112
SIC : 3533
ISIN : NL0000200384
Share Class Description:
MEX:CLB: Ordinary SharesTotal Employee Number:
3,300Description
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.14 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.45 | |||||
Interest Coverage | 4.14 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.84 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.3 | |||||
3-Year EBITDA Growth Rate | 6.4 | |||||
3-Year EPS without NRI Growth Rate | 9.6 | |||||
3-Year FCF Growth Rate | 14.7 | |||||
3-Year Book Growth Rate | 13.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 23.43 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.99 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.05 | |||||
Quick Ratio | 1.5 | |||||
Cash Ratio | 0.22 | |||||
Days Inventory | 48.57 | |||||
Days Sales Outstanding | 78.32 | |||||
Days Payable | 32.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 6.82 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 17.12 | |||||
Operating Margin % | 8.57 | |||||
Net Margin % | 5.53 | |||||
EBITDA Margin % | 13.08 | |||||
FCF Margin % | 3.55 | |||||
OCF Margin % | 6.61 | |||||
ROE % | 10.99 | |||||
ROA % | 4.91 | |||||
ROIC % | 6.24 | |||||
3-Year ROIIC % | 197.46 | |||||
ROC (Joel Greenblatt) % | 21.52 | |||||
ROCE % | 11.05 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.35 | |||||
Forward PE Ratio | 77.61 | |||||
PE Ratio without NRI | 16.84 | |||||
Shiller PE Ratio | 11.52 | |||||
Price-to-Owner-Earnings | 25.9 | |||||
PS Ratio | 1.02 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 3.38 | |||||
Price-to-Free-Cash-Flow | 29.43 | |||||
Price-to-Operating-Cash-Flow | 15.6 | |||||
EV-to-EBIT | 12.59 | |||||
EV-to-EBITDA | 9.89 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-FCF | 37.14 | |||||
Price-to-GF-Value | 0.64 | |||||
Price-to-Projected-FCF | 1.14 | |||||
Price-to-Median-PS-Value | 0.41 | |||||
Price-to-Graham-Number | 1.59 | |||||
Earnings Yield (Greenblatt) % | 7.94 | |||||
FCF Yield % | 3.46 | |||||
Forward Rate of Return (Yacktman) % | 6.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Core Laboratories Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 9,624.174 | ||
| EPS (TTM) (MXN) | 12.275 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -65.65 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 0.04 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 856.38 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 856.38 - 856.38 | ||
| Shares Outstanding (Mil) | 46.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Core Laboratories Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Core Laboratories Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-23 08:30 | In 101 days | ||
| Third quarter earnings results for 2026 | 2026-10-22 | In 99 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 08:30 | In 16 days | ||
| Second quarter earnings results for 2026 | 2026-07-29 | In 14 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-24 08:30 | In 10 days | ||
| Second quarter earnings results for 2026 | 2026-07-23 | In 8 days | ||
| General meeting for 2026 | 2026-05-12 09:00 | 856.38 (+0.00%) | ||
| USD 0.010000 Cash Dividend | 2026-05-11 | 856.38 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-30 08:30 | 856.38 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 856.38 (+0.00%) |
Show
Entries
Core Laboratories Inc Frequently Asked Questions
What is Core Laboratories Inc(MEX:CLB)'s stock price today?
The current price of MEX:CLB is MXN856.38. The 52 week high of MEX:CLB is MXN856.38 and 52 week low is MXN856.38.
When is next earnings date of Core Laboratories Inc(MEX:CLB)?
The next earnings date of Core Laboratories Inc(MEX:CLB) is 2026-07-23 Est..
Does Core Laboratories Inc(MEX:CLB) pay dividends? If so, how much?
Core Laboratories Inc(MEX:CLB) does not pay dividend.
Press Release
Articles on Core Laboratories Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers